Trial Profile
A Multicenter, Active-Controlled, Randomized Study To Evaluate The Safety And Efficacy Of Levofloxacin Versus Ceftriaxone Sodium Or Cefuroxime Axetil In The Treatment Of Community-Acquired Pneumonia In Adults
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 30 May 2016
Price :
$35
*
At a glance
- Drugs Levofloxacin (Primary) ; Ceftriaxone; Cefuroxime axetil
- Indications Bacterial infections; Community-acquired pneumonia
- Focus Therapeutic Use
- Sponsors Daiichi Sankyo Company; Janssen Research & Development
- 19 Oct 2006 New trial record.